Atlas Trials

Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis

Clinical trial NCT07304271 · RECRUITING

Trial details

NCT number
NCT07304271
Sponsor
Magnus Nilsson
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Gastric Cancer Peritoneal Metastases
Start date
2025-11-05
Primary completion
2031-01-31
Enrollment
262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.